Global Influenza Vaccine Professional Survey Report 2023, Forecast to 2028

Publisher Name :
Date: 14-Nov-2023
No. of pages: 109

Influenza Vaccine is vaccines that protect against the four influenza viruses that research indicates most common during the upcoming season.

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.

Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.

Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.

2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.

But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China's reopening could provide a much-needed and timely boost.

The report researches and analyzes the influence of the Influenza Vaccine industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.

Market Segment by Product Type

- Whole Virus Vaccines

- Split Virus Vaccines

- Subunit Vaccines

- Live Attenuated Virus Vaccines

Market Segment by Product Application

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

Finally, the report provides detailed profile and data information analysis of leading company.

- CSL

- Mylan

- GSK

- Johnson & Johnson

- Sanofi Pasteur

- Pfizer

- AstraZeneca

Insights and Tools:

We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.

The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.

The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.

Research Objectives

- 1.To study and analyze the global Influenza Vaccine consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.

- 2.To understand the structure of Influenza Vaccine market by identifying its various subsegments.

- 3.Focuses on the key global Influenza Vaccine manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.

- 4.To analyze the Influenza Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- 6.To project the consumption of Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).

- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- 8.To strategically profile the key players and comprehensively analyze their growth strategies.

Global Influenza Vaccine Professional Survey Report 2023, Forecast to 2028

Table of Contents

Global Influenza Vaccine Professional Survey Report Report 2023, Forecast to 2028

1 Market Study Overview
1.1 Study Objectives
1.2 Influenza Vaccine Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Influenza Vaccine Segment by Type
2.1.1 Whole Virus Vaccines
2.1.2 Split Virus Vaccines
2.1.3 Subunit Vaccines
2.1.4 Live Attenuated Virus Vaccines
2.2 Market Analysis by Application
2.2.1 For Children (6 months to 3 years)
2.2.2 For Adults and Children over 3 years
2.3 Global Influenza Vaccine Market Comparison by Regions (2018-2028)
2.3.1 Global Influenza Vaccine Market Size (2018-2028)
2.3.2 North America Influenza Vaccine Status and Prospect (2018-2028)
2.3.3 Europe Influenza Vaccine Status and Prospect (2018-2028)
2.3.4 Asia-pacific Influenza Vaccine Status and Prospect (2018-2028)
2.3.5 South America Influenza Vaccine Status and Prospect (2018-2028)
2.3.6 Middle East & Africa Influenza Vaccine Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Influenza Vaccine Industry Impact
2.5.1 Influenza Vaccine Business Impact Assessment - Covid-19
2.5.2 Market Trends and Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Influenza Vaccine Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Influenza Vaccine Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Influenza Vaccine Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Influenza Vaccine Manufacturer Market Share
3.5 Top 10 Influenza Vaccine Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Influenza Vaccine Market
3.7 Key Manufacturers Influenza Vaccine Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Influenza Vaccine Industry Key Manufacturers
4.1 CSL
4.1.1 Company Details
4.1.2 CSL Influenza Vaccine Product Introduction, Application and Specification
4.1.3 CSL Influenza Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 CSL News
4.2 Mylan
4.2.1 Company Details
4.2.2 Mylan Influenza Vaccine Product Introduction, Application and Specification
4.2.3 Mylan Influenza Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Mylan News
4.3 GSK
4.3.1 Company Details
4.3.2 GSK Influenza Vaccine Product Introduction, Application and Specification
4.3.3 GSK Influenza Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 GSK News
4.4 Johnson & Johnson
4.4.1 Company Details
4.4.2 Johnson & Johnson Influenza Vaccine Product Introduction, Application and Specification
4.4.3 Johnson & Johnson Influenza Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Johnson & Johnson News
4.5 Sanofi Pasteur
4.5.1 Company Details
4.5.2 Sanofi Pasteur Influenza Vaccine Product Introduction, Application and Specification
4.5.3 Sanofi Pasteur Influenza Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Sanofi Pasteur News
4.6 Pfizer
4.6.1 Company Details
4.6.2 Pfizer Influenza Vaccine Product Introduction, Application and Specification
4.6.3 Pfizer Influenza Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Pfizer News
4.7 AstraZeneca
4.7.1 Company Details
4.7.2 AstraZeneca Influenza Vaccine Product Introduction, Application and Specification
4.7.3 AstraZeneca Influenza Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.5 AstraZeneca News

5 Global Influenza Vaccine Sales Categorized by Regions
5.1 Global Influenza Vaccine Revenue, Sales and Market Share by Regions
5.1.1 Global Influenza Vaccine Sales and Market Share by Regions (2018-2023)
5.1.2 Global Influenza Vaccine Revenue and Market Share by Regions (2018-2023)
5.2 North America Influenza Vaccine Sales and Growth Rate (2018-2023)
5.3 Europe Influenza Vaccine Sales and Growth Rate (2018-2023)
5.4 Asia-pacific Influenza Vaccine Sales and Growth Rate (2018-2023)
5.5 South America Influenza Vaccine Sales and Growth Rate (2018-2023)
5.6 Middle East & Africa Influenza Vaccine Sales and Growth Rate (2018-2023)

6 North America Influenza Vaccine Market Size Categorized by Countries
6.1 North America Influenza Vaccine Sales, Revenue and Market Share by Countries
6.1.1 North America Influenza Vaccine Sales (Volume) by Countries (2018-2023)
6.1.2 North America Influenza Vaccine Revenue by Countries (2018-2023)
6.1.3 United States Influenza Vaccine Sales and Growth Rate (2018-2023)
6.1.4 Canada Influenza Vaccine Sales and Growth Rate (2018-2023)
6.1.5 Mexico Influenza Vaccine Sales and Growth Rate (2018-2023)
6.2 North America Influenza Vaccine Revenue (Value) by Manufacturers
6.3 North America Influenza Vaccine Sales and Market Share by Type (2018-2023)
6.4 North America Influenza Vaccine Sales Market Share by Application (2018-2023)

7 Europe Influenza Vaccine Market Size Categorized by Countries
7.1 Europe Influenza Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Europe Influenza Vaccine Sales (Volume) by Countries (2018-2023)
7.1.2 Europe Influenza Vaccine Revenue by Countries (2018-2023)
7.1.3 Germany Influenza Vaccine Sales and Growth Rate (2018-2023)
7.1.4 UK Influenza Vaccine Sales and Growth Rate (2018-2023)
7.1.5 France Influenza Vaccine Sales and Growth Rate (2018-2023)
7.1.6 Russia Influenza Vaccine Sales and Growth Rate (2018-2023)
7.1.7 Italy Influenza Vaccine Sales and Growth Rate (2018-2023)
7.1.8 Spain Influenza Vaccine Sales and Growth Rate (2018-2023)
7.2 Europe Influenza Vaccine Revenue (Value) by Manufacturers
7.3 Europe Influenza Vaccine Sales and Market Share by Type (2018-2023)
7.4 Europe Influenza Vaccine Sales Market Share by Application (2018-2023)

8 Asia-Pacific Influenza Vaccine Market Size Categorized by Countries
8.1 Asia-pacific Influenza Vaccine Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Influenza Vaccine Sales (Volume) by Countries (2018-2023)
8.1.2 Asia-pacific Influenza Vaccine Revenue by Countries (2018-2023)
8.1.3 China Influenza Vaccine Sales and Growth Rate (2018-2023)
8.1.4 South Korea Influenza Vaccine Sales and Growth Rate (2018-2023)
8.1.5 Japan Influenza Vaccine Sales and Growth Rate (2018-2023)
8.1.6 Australia Influenza Vaccine Sales and Growth Rate (2018-2023)
8.1.7 India Influenza Vaccine Sales and Growth Rate (2018-2023)
8.1.8 Southeast Asia Influenza Vaccine Sales and Growth Rate (2018-2023)
8.2 Asia-pacific Influenza Vaccine Revenue (Value) by Manufacturers
8.3 Asia-pacific Influenza Vaccine Sales and Market Share by Type (2018-2023)
8.4 Asia-pacific Influenza Vaccine Sales Market Share by Application (2018-2023)

9 South America Influenza Vaccine Market Size Categorized by Countries
9.1 South America Influenza Vaccine Sales, Revenue and Market Share by Countries
9.1.1 South America Influenza Vaccine Sales (Volume) by Countries (2018-2023)
9.1.2 South America Influenza Vaccine Revenue by Countries (2018-2023)
9.1.3 Brazil Influenza Vaccine Sales and Growth Rate (2018-2023)
9.2 South America Influenza Vaccine Sales and Market Share by Type (2018-2023)
9.3 South America Influenza Vaccine Sales Market Share by Application (2018-2023)

10 Middle East and Africa Influenza Vaccine Market Size Categorized by Countries
10.1 Middle East and Africa Influenza Vaccine Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Influenza Vaccine Sales (Volume) by Countries (2018-2023)
10.1.2 Middle East and Africa Influenza Vaccine Revenue by Countries (2018-2023)
10.1.3 GCC Countries Influenza Vaccine Sales and Growth Rate (2018-2023)
10.1.4 Turkey Influenza Vaccine Sales and Growth Rate (2018-2023)
10.1.5 Egypt Influenza Vaccine Sales and Growth Rate (2018-2023)
10.1.6 South America Influenza Vaccine Sales and Growth Rate (2018-2023)
10.2 Middle East and Africa Influenza Vaccine Sales and Market Share by Type
10.3 Middle East and Africa Influenza Vaccine Sales Market Share by Application (2018-2023)

11 Global Influenza Vaccine Market Segment by Type
11.1 Global Influenza Vaccine Revenue, Sales and Market Share by Type (2018-2023)
11.1.1 Global Influenza Vaccine Sales and Market Share by Type (2018-2023)
11.1.2 Global Influenza Vaccine Revenue and Market Share by Type (2018-2023)
11.2 Whole Virus Vaccines Sales Growth Rate and Price
11.2.1 Global Whole Virus Vaccines Sales Growth Rate (2018-2023)
11.2.2 Global Whole Virus Vaccines Price (2018-2023)
11.3 Split Virus Vaccines Sales Growth Rate and Price
11.3.1 Global Split Virus Vaccines Sales Growth Rate (2018-2023)
11.3.2 Global Split Virus Vaccines Price (2018-2023)
11.4 Subunit Vaccines Sales Growth Rate and Price
11.4.1 Global Subunit Vaccines Sales Growth Rate (2018-2023)
11.4.2 Global Subunit Vaccines Price (2018-2023)
11.5.1 Global Live Attenuated Virus Vaccines Sales Growth Rate (2018-2023)
11.5.2 Global Live Attenuated Virus Vaccines Price (2018-2023)

12 Global Influenza Vaccine Market Segment by Application
12.1 Global Influenza Vaccine Sales Market Share by Application (2018-2023)
12.2 For Children (6 months to 3 years) Sales Growth Rate (2018-2023)
12.3 For Adults and Children over 3 years Sales Growth Rate (2018-2023)

13 Global Influenza Vaccine Market Forecast
13.1 Global Influenza Vaccine Revenue, Sales and Growth Rate (2023-2028)
13.2 Influenza Vaccine Market Forecast by Regions (2023-2028)
13.2.1 North America Influenza Vaccine Market Forecast (2023-2028)
13.2.2 Europe Influenza Vaccine Market Forecast (2023-2028)
13.2.3 Asia-Pacific Influenza Vaccine Market Forecast (2023-2028)
13.2.4 South America Influenza Vaccine Market Forecast (2023-2028)
13.2.5 Middle East & Africa Influenza Vaccine Market Forecast (2023-2028)
13.3 Influenza Vaccine Market Forecast by Type (2023-2028)
13.3.1 Global Influenza Vaccine Sales Forecast by Type (2023-2028)
13.3.2 Global Influenza Vaccine Market Share Forecast by Type (2023-2028)
13.4 Influenza Vaccine Market Forecast by Application (2023-2028)
13.4.1 Global Influenza Vaccine Sales Forecast by Application (2023-2028)
13.4.2 Global Influenza Vaccine Market Share Forecast by Application (2023-2028)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Influenza Vaccine Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Influenza Vaccine Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers


List of Tables and Figures

Figure Product Picture Influenza Vaccine
Figure Market Concentration Ratio and Market Maturity Analysis of Influenza Vaccine
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Influenza Vaccine Market Size by Type
Figure Global Market Share of Influenza Vaccine by Type in 2022
Figure Whole Virus Vaccines Picture
Figure Split Virus Vaccines Picture
Figure Subunit Vaccines Picture
Figure Live Attenuated Virus Vaccines Picture
Table Global Influenza Vaccine Market Size (Volume) by Application
Figure For Children (6 months to 3 years) Picture
Figure For Adults and Children over 3 years Picture
Table Global Influenza Vaccine Comparison by Regions (M USD) 2018-2028
Figure Global Influenza Vaccine Market Size (Million US$) (2018-2028)
Figure North America Influenza Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Influenza Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Figure Asia-pacific Influenza Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Figure South America Influenza Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Figure Middle East & Africa Influenza Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Influenza Vaccine Sales by Manufacturer (2018-2023)
Figure Global Influenza Vaccine Sales Market Share by Manufacturer in 2022
Table Global Influenza Vaccine Revenue by Manufacturer (2018-2023)
Figure Global Influenza Vaccine Revenue Market Share by Manufacturer in 2022
Table Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Influenza Vaccine Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Influenza Vaccine Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Influenza Vaccine Market
Table Key Manufacturers Influenza Vaccine Product Type
Table Mergers & Acquisitions Planning
Table CSL Company Profile
Table Influenza Vaccine Product Introduction, Application and Specification of CSL
Table Influenza Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CSL 2018-2023
Table CSL Main Business
Table CSL Recent Development
Table Mylan Company Profile
Table Influenza Vaccine Product Introduction, Application and Specification of Mylan
Table Influenza Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2018-2023
Table Mylan Main Business
Table Mylan Recent Development
Table GSK Company Profile
Table Influenza Vaccine Product Introduction, Application and Specification of GSK
Table Influenza Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GSK 2018-2023
Table GSK Main Business
Table GSK Recent Development
Table Johnson & Johnson Company Profile
Table Influenza Vaccine Product Introduction, Application and Specification of Johnson & Johnson
Table Influenza Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2018-2023
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Sanofi Pasteur Company Profile
Table Influenza Vaccine Product Introduction, Application and Specification of Sanofi Pasteur
Table Influenza Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi Pasteur 2018-2023
Table Sanofi Pasteur Main Business
Table Sanofi Pasteur Recent Development
Table Pfizer Company Profile
Table Influenza Vaccine Product Introduction, Application and Specification of Pfizer
Table Influenza Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2018-2023
Table Pfizer Main Business
Table Pfizer Recent Development
Table AstraZeneca Company Profile
Table Influenza Vaccine Product Introduction, Application and Specification of AstraZeneca
Table Influenza Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2018-2023
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Figure Global Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Global Influenza Vaccine Revenue and Growth Rate (2018-2023)
Table Global Influenza Vaccine Sales by Regions (2018-2023)
Figure Global Influenza Vaccine Sales Market Share by Regions in 2022
Table Global Influenza Vaccine Revenue by Regions (2018-2023)
Figure Global Influenza Vaccine Revenue Market Share by Regions in 2022
Figure North America Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Europe Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Asia-pacific Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure South America Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Middle East & Africa Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure North America Influenza Vaccine Revenue and Growth Rate (2018-2023)
Table North America Influenza Vaccine Sales (Volume) by Countries (2018-2023)
Table North America Influenza Vaccine Sales Market Share by Countries (2018-2023)
Figure North America Influenza Vaccine Sales Market Share by Countries in 2022
Table North America Influenza Vaccine Revenue by Countries (2018-2023)
Table North America Influenza Vaccine Revenue Market Share by Countries (2018-2023)
Figure North America Influenza Vaccine Revenue Market Share by Countries in 2022
Figure United States Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Canada Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Mexico Influenza Vaccine Sales and Growth Rate (2018-2023)
Table North America Influenza Vaccine Revenue by Manufacturer (2022)
Figure North America Influenza Vaccine Revenue Market Share by Manufacturer in 2022
Table North America Influenza Vaccine Sales by Type (2018-2023)
Table North America Influenza Vaccine Sales Share by Type (2018-2023)
Table North America Influenza Vaccine Sales by Application (2018-2023)
Table North America Influenza Vaccine Sales Share by Application (2018-2023)
Figure Europe Influenza Vaccine Revenue and Growth Rate (2018-2023)
Table Europe Influenza Vaccine Sales (Volume) by Countries (2018-2023)
Table Europe Influenza Vaccine Sales Market Share by Countries (2018-2023)
Figure Europe Influenza Vaccine Sales Market Share by Countries in 2022
Table Europe Influenza Vaccine Revenue by Countries (2018-2023)
Table Europe Influenza Vaccine Revenue Market Share by Countries (2018-2023)
Figure Europe Influenza Vaccine Revenue Market Share by Countries in 2022
Figure Germany Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure UK Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure France Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Russia Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Italy Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Spain Influenza Vaccine Sales and Growth Rate (2018-2023)
Table Europe Influenza Vaccine Revenue by Manufacturer (2022)
Figure Europe Influenza Vaccine Revenue Market Share by Manufacturer in 2022
Table Europe Influenza Vaccine Sales by Type (2018-2023)
Table Europe Influenza Vaccine Sales Share by Type (2018-2023)
Table Europe Influenza Vaccine Sales by Application (2018-2023)
Table Europe Influenza Vaccine Sales Share by Application (2018-2023)
Figure Asia-pacific Influenza Vaccine Revenue and Growth Rate (2018-2023)
Table Asia-pacific Influenza Vaccine Sales (Volume) by Countries (2018-2023)
Table Asia-pacific Influenza Vaccine Sales Market Share by Countries (2018-2023)
Figure Asia-pacific Influenza Vaccine Sales Market Share by Countries in 2022
Table Asia-pacific Influenza Vaccine Revenue by Countries (2018-2023)
Table Asia-pacific Influenza Vaccine Revenue Market Share by Countries (2018-2023)
Figure Asia-pacific Influenza Vaccine Revenue Market Share by Countries in 2022
Figure China Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure South Korea Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Japan Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Australia Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure India Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Southeast Asia Influenza Vaccine Sales and Growth Rate (2018-2023)
Table Asia-pacific Influenza Vaccine Revenue by Manufacturer (2022)
Figure Asia-pacific Influenza Vaccine Revenue Market Share by Manufacturer in 2022
Table Asia-pacific Influenza Vaccine Sales by Type (2018-2023)
Table Asia-pacific Influenza Vaccine Sales Share by Type (2018-2023)
Table Asia-pacific Influenza Vaccine Sales by Application (2018-2023)
Table Asia-pacific Influenza Vaccine Sales Share by Application (2018-2023)
Figure South America Influenza Vaccine Revenue and Growth Rate (2018-2023)
Table South America Influenza Vaccine Sales (Volume) by Countries (2018-2023)
Table South America Influenza Vaccine Sales Market Share by Countries (2018-2023)
Figure South America Influenza Vaccine Sales Market Share by Countries in 2020
Table South America Influenza Vaccine Revenue by Countries (2018-2023)
Table South America Influenza Vaccine Revenue Market Share by Countries (2018-2023)
Figure South America Influenza Vaccine Revenue Market Share by Countries in 2020
Figure Brazil Influenza Vaccine Sales and Growth Rate (2018-2023)
Table South America Influenza Vaccine Sales by Type (2018-2023)
Table South America Influenza Vaccine Sales Share by Type (2018-2023)
Table South America Influenza Vaccine Revenue by Type (2018-2023)
Table South America Influenza Vaccine Revenue Share by Type (2018-2023)
Table South America Influenza Vaccine Sales by Application (2018-2023)
Table South America Influenza Vaccine Sales Share by Application (2018-2023)
Figure Middle East and Africa Influenza Vaccine Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Influenza Vaccine Sales (Volume) by Countries (2018-2023)
Table Middle East and Africa Influenza Vaccine Sales Market Share by Countries (2018-2023)
Figure Middle East and Africa Influenza Vaccine Sales Market Share by Countries in 2020
Table Middle East and Africa Influenza Vaccine Revenue by Countries (2018-2023)
Table Middle East and Africa Influenza Vaccine Revenue Market Share by Countries (2018-2023)
Figure Middle East and Africa Influenza Vaccine Revenue Market Share by Countries in 2020
Figure GCC Countries Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Turkey Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure Egypt Influenza Vaccine Sales and Growth Rate (2018-2023)
Figure South Africa Influenza Vaccine Sales and Growth Rate (2018-2023)
Table Middle East and Africa Influenza Vaccine Sales by Type (2018-2023)
Table Middle East and Africa Influenza Vaccine Sales Share by Type (2018-2023)
Table Middle East and Africa Influenza Vaccine Revenue by Type (2018-2023)
Table Middle East and Africa Influenza Vaccine Revenue Share by Type (2018-2023)
Table Middle East and Africa Influenza Vaccine Sales by Application (2018-2023)
Table Middle East and Africa Influenza Vaccine Sales Share by Application (2018-2023)
Table Global Influenza Vaccine Sales by Type (2018-2023)
Table Global Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure Global Influenza Vaccine Sales Market Share by Type in 2022
Table Global Influenza Vaccine Revenue by Type (2018-2023)
Table Global Influenza Vaccine Revenue Market Share by Type (2018-2023)
Figure Global Influenza Vaccine Revenue Market Share by Type in 2020
Figure Global Whole Virus Vaccines Sales Growth Rate (2018-2023)
Figure Global Whole Virus Vaccines Price (2018-2023)
Figure Global Split Virus Vaccines Sales Growth Rate (2018-2023)
Figure Global Split Virus Vaccines Price (2018-2023)
Figure Global Subunit Vaccines Sales Growth Rate (2018-2023)
Figure Global Subunit Vaccines Price (2018-2023)
Figure Global Live Attenuated Virus Vaccines Sales Growth Rate (2018-2023)
Figure Global Live Attenuated Virus Vaccines Price (2018-2023)
Table Global Influenza Vaccine Sales by Application (2018-2023)
Table Global Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure Global Influenza Vaccine Sales Market Share by Application in 2022
Figure Global For Children (6 months to 3 years) Sales Growth Rate (2018-2023)
Figure Global For Adults and Children over 3 years Sales Growth Rate (2018-2023)
Figure Global Influenza Vaccine Sales and Growth Rate (2023-2028)
Figure Global Influenza Vaccine Revenue and Growth Rate (2023-2028)
Table Global Influenza Vaccine Sales Forecast by Regions (2018-2023)
Table Global Influenza Vaccine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Influenza Vaccine Market Forecast (2023-2028)
Figure Europe Sales Influenza Vaccine Market Forecast (2023-2028)
Figure Asia-Pacific Sales Influenza Vaccine Market Forecast (2023-2028)
Figure South America Sales Influenza Vaccine Market Forecast (2023-2028)
Figure Middle East & Africa Sales Influenza Vaccine Market Forecast (2023-2028)
Table Global Influenza Vaccine Sales Forecast by Type (2023-2028)
Table Global Influenza Vaccine Market Share Forecast by Type (2023-2028)
Table Global Influenza Vaccine Sales Forecast by Application (2023-2028)
Table Global Influenza Vaccine Market Share Forecast by Application (2023-2028)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Vaccine
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs